Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

8.71
Delayed Data
As of 4:14pm ET
 +0.50 / +6.09%
Today’s Change
2.38
Today|||52-Week Range
8.74
+106.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash60.7M68.6M55.7M56.6M
 
 
 
 
 
Short Term Investment Cash4.9M7.9M-12.9M907.0K
 
 
 
 
 
Cash & Short Term Investments108.2M111.0M178.3M109.9M
 
 
 
 
 
 
ReceivablesReceivables9.6M5.4M6.3M39.3M
 
 
 
 
 
 
InventoriesInventories------0.00--
 
Current AssetsOther Current Assets3.5M5.2M6.4M6.1M
 
 
 
 
 
Current Assets121.3M121.7M191.0M155.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross88.5M90.4M58.4M60.3M
 
 
 
 
 
Depreciation-78.5M-82.3M-53.4M-53.6M
 
 
 
 
 
Other Assets4.2M8.6M1.6M6.3M
 
 
 
 
 
Total Assets136.0M139.1M198.2M168.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.4M7.0M4.6M10.1M
 
 
 
 
 
Accrued Expenses6.7M11.5M20.1M20.2M
 
 
 
 
 
Other Current Liabilities35.7M37.6M30.3M33.7M
 
 
 
 
 
Other Liabilities50.6M52.7M42.4M52.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt99.0M104.0M107.3M113.7M
 
 
 
 
 
Other Liabilities465.0K640.0K496.0K4.8M
 
 
 
 
 
Total Liabilities157.9M164.8M155.6M206.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-21.9M-25.7M42.7M-37.9M
 
 
 
 
 
Total Shareholder Equity-21.9M-25.7M42.7M-37.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding116.9M131.8M142.1M143.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.